3630 results for «2264»

Filter By

3630 results

Imaging for tricuspid valve interventions: anatomical assessment, grading of severity and peri-procedural guidance

27 Nov 2022 – From PCR London Valves 2022

Consult these presentations on imaging for tricuspid valve interventions to learn more about how to adequately assess tricuspid valve anatomy and identify which criteria determine procedure-related prognosis, how to determine the severity of tricuspid regurgitation and identify key pitfalls in assessment, as well as how to guide a...

Imaging for tricuspid valve interventions: anatomical assessment, grading of severity and peri-procedural guidance

TAVI: new devices and procedural refinements

27 Nov 2022 – From PCR London Valves 2022

Consult this session dedicated to TAVI new devices and procedural refinements to learn more about Meril's Myval transcatheter heart valve, the newest EVOLUT-FX self-expanding supra-annular valve, the OctaAlign technique with the novel Myval octacor transcatheter heart valve, and more!

TAVI: new devices and procedural refinements

Transfemoral TAVI access using intravascular lithotripsy in patients with challenging peripheral vascular disease

28 Nov 2022 – From PCR London Valves 2022

Watch this session to appreciate why it is better to tackle difficult transfemoral access rather than considering alternative access strategies and understand how intravascular lithotripsy mitigates procedural risk.

Transfemoral TAVI access

Contemporary best clinical practice for TAVI

28 Nov 2022 – From PCR London Valves 2022

Watch this case-based presentation to learn how to choose the right valve for the individual patient and how patient-tailored valve implantation techniques may optimise long-term outcomes.

Contemporary best clinical

TAVI innovations

27 Nov 2022 – From PCR London Valves 2022

Discover some of the latest innovations in TAVI presented at PCR LV 2022: zero-contrast TAVI, emerging technique for coronary protection in ViV TAVR, first dedicated splitting device in a degenerated TAVR at risk for double coronary obstruction, and much more!

TAVI innovations

Clinical update and best practices for optimal large bore management with the MANTA closure device

29 Nov 2022 – From PCR London Valves 2022

Watch this session if you want to get an overview of the most recent clinical evidence regarding large bore closure devices and participate in a critical discussion on the most relevant clinical data and best practices in large bore management.

Clinical update and best

Tricuspid interventions

27 Nov 2022 – From PCR London Valves 2022

How to manage tricuspid valve disease in a patient with atrial fibrillation, transcatheter tricuspid valve repair with transthoracic echocardiography guidance, or a patient with severe tricuspid regurgitation with a novel transcatheter treatment? Watch this PCR LV 2022 session for answers!

Tricuspid interventions

Primary mitral regurgitation: key imaging requirements for diagnosis and procedural planning

27 Nov 2022 – From PCR London Valves 2022

In this session, find out more about the most common types of primary mitral regurgitation and methods for their evaluation, the principal indications for intervention, as well as the available modes of therapy (surgical/transcatheter) and most appropriate choices for individual patients.

Primary mitral regurgitation: key imaging requirements for diagnosis and procedural planning

Rapid-fire clinical cases: session 2

27 Nov 2022 – From PCR London Valves 2022

Discover in the same PCR LV 2022 session a TAVI for pure aortic regurgitation in degenerated aortic homograft, an embolised Myval transcatheter heart valve to AAA, or a challenging ViV TAVI, and much more!

Rapid-fire clinical cases: session 2

Twenty years of progress - What we have achieved - LIVE case

27 Nov 2022 – From PCR London Valves 2022

  • Part 1: TAVI by axillary access (Live)
    An 80-year-old female with peripheral arterial disease presents a symptomatic severe aortic stenosis with small annulus and preserved LV function.
    The operators implant, by axillary access, an Evolut pro 26 mm, on general anaesthesia, with predilatation (Balloon 18 mm) and post-dilatation...
Twenty years of progress - What we have achieved

Ensuring optimal TAVI outcomes - LIVE case

27 Nov 2022 – From PCR London Valves 2022

A 75-year-old female with diabetes and history of ischemic stroke 5 years ago presents a symptomatic severe aortic valve stenosis in a small annulus.
After pre-dilatation (18 mm balloon), the operators implant an Acurate neo2 23 mm with a sentinel cerebral embolic protection device. Watch them perform...

Ensuring optimal TAVI outcomes

TAVI step by step: from femoral puncture to procedural success

27 Nov 2022 – From PCR London Valves 2022

Look at these presentations to get insights into the basics of CT evaluation for TAVI procedural planning, and discover how to optimise every aspect of the TAVI procedure and ensure the best clinical outcomes even in difficult anatomies. 

TAVI step by step: from femoral puncture to procedural success

Hot TAVI topics - Emerging indications

27 Nov 2022 – From PCR London Valves 2022

Consult this session on hot TAVI topics to learn more about the under-treatment problem of patients with aortic valve disease, the rationale behind emerging TAVI indications and ongoing trials, as well as the nuances of patient selection and the key role of cardiac imaging in identifying markers of...

Hot TAVI topics - Emerging indications

Treatment of calcified lesions

07 Oct 2022 – From AICT-AsiaPCR 2022

Consider a 66-year-old man, hypertensive and diabetic for 10 years, with history of recurrent substernal chest pain and exertional dyspnea, who presented with easy fatigability and shortness of breath, or a 72-year-old man on dialysis who presented with STEMI and severe calcified stenosis of LAD/DI bifurcation,...

Treatment of calcified lesions

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Andreas Baumbach and Patrick W. Serruys in order to understand what is a healing-targeted (HT) drug-eluting stent (DES) and what are the potential benefits, to review recent clinical data of the HT DES from the PIONEER III trial, and to learn about...

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

Clinical event reductions in high-risk hypertension patients treated with renal denervation

18 May 2021 – From EuroPCR 2021

Watch this session presented by Roland Schmieder in order to learn about the long-term safety and efficacy of renal denervation in high-risk subgroups from the largest renal denervation data set of real-world patients, to understand how clinical event rates could be reduced following renal denervation as compared...

Clinical event reductions in high-risk hypertension patients treated with renal denervation

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

18 May 2021 – From EuroPCR 2021

Watch this session presented by Juan F. Iglesias in order to review the role of ultrathin DES in optimising clinical outcomes in STEMI patients, to learn about the BIOSTEMI trial and its new two-year outcomes, and to assess the impact of the BIOSTEMI trial on your daily practice.

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

Guiding primary PCI using high-definition intravascular ultrasound

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen in order to understand the pitfalls of primary PCI, to learn how IVUS can improve outcomes, and to understand the importance of plaque and thrombus quantification.

Guiding primary PCI using high-definition intravascular ultrasound

Leading dose solutions for your interventions

18 May 2021 – From EuroPCR 2021

Watch this session presented by Laurent Fieldman in order to understand how innovations can help you optimising dose in your procedures, to learn about latest dose reduction tools for complex interventions, and to review expert perspective on using innovative dose reduction tools.

Leading dose solutions for your interventions

The future of PCI seems bright - The MagicTouch sirolimus-coated balloon

18 May 2021 – From EuroPCR 2021

Watch this session presented by Antonio Colombo, Bernardo Cortese and Sandeep Basavarajaiah in order to understand the strategy behind using a DCB as a proper solution for CAD and the result and potential of using a Sirolimus DCB in coronary intervention, as well as to get insights into real...

The future of PCI seems bright - The MagicTouch sirolimus-coated balloon
Didn’t find what you were looking for?